Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FQQ0N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,790
Award facts
- Contract value 100% obligated
- $11,789.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,789.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with performance in Conshohocken, Pennsylvania and completion by December 8, 2025. This competitively awarded contract, issued November 14, 2025, carries no set-aside designation. The order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as the comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. Calquence (acalabrutinib) is a targeted cancer therapy used in hematologic malignancies, demonstrating the company's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The firm fixed-price structure and competitive award reflect AmerisourceBergen's demonstrated capability to meet federal procurement requirements for critical medical supplies.
Quick answers
Who was awarded contract SPE2DR26FQQ0N?
SPE2DR26FQQ0N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FQQ0N worth?
The government has obligated $11,790 on SPE2DR26FQQ0N.
Is contract SPE2DR26FQQ0N an order under another contract?
Yes. SPE2DR26FQQ0N is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ0N competed?
The extent of competition for SPE2DR26FQQ0N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award